1. Question: Kenneth is taking warfarin and is asking about what he can take for minor aches and pains. The best recommendation is:
2. Question: Juanita had a DVT and was on heparin in the hospital and was discharged on warfarin. She asks her primary care provider NP why she was getting both medications while in the hospital. The best response is to:
3. Question: The safest drug to use to treat pregnant women who require anticoagulant therapy is:
4. Question: The average starting dose of warfarin is 5 mg daily. Higher doses of 7.5 mg daily should be considered in which patients?
5. Question: Cecil and his wife are traveling to Southeast Asia on vacation and he has come into the clinic to review his medications. He is healthy with only mild hypertension that is well controlled. He asks about getting “a shot” to prevent blood clots like his friend Ralph did before international travel. The correct respond would be:
6. Question: Robert, age 51 years, has been told by his primary care provider (PCP) to take an aspirin a day. Why would this be recommended?
7. Question: Sally has been prescribed aspirin 320 mg per day for her atrial fibrillation. She also takes aspirin four or more times a day for arthritis pain. What are the symptoms of aspirin toxicity she would need to be evaluated for:
8. Question: Patient education when prescribing clopidogrel includes:
9. Question: For patients taking warfarin INRs are best drawn:
10. Question: Patients receiving heparin therapy require monitoring of:
11. Question: The routine monitoring recommended for low molecular weight heparin is:
12. Question: When writing a prescription for warfarin it is common to write ____ on the prescription.
13. Question: Education of patients who are taking warfarin includes discussing their diet. Instructions include:
14. Question: Patients who are being treated with epoetin alfa need to be monitored for the development of:
15. Question: The FDA issued a safety announcement regarding the use of erythropoiesis-stimulating agents (ESAs) in 2010 with the recommendation that:
16. Question: When patients are started on darbepoetin alfa (Aranesp) they need monitoring of their blood counts to determine a dosage adjustment in:
17. Question: Jim is having a hip replacement surgery and would like to self-donate blood for the surgery. In addition to being prescribed epogen alpha he should also be prescribed:
18. Question: Monitoring for a patient being prescribed iron for iron deficiency anemia includes:
19. Question: Patient education regarding taking iron replacements includes:
20. Question: Patients with pernicious anemia require treatment with:
21. Question: The first lab value indication that Vitamin B₁₂ therapy is adequately treating pernicious anemia is:
22. Question: Patients who are beginning therapy with Vitamin B₁₂ need to be monitored for:

Week 5 Chapter 19: Drugs Affecting the Immune System

1. Question: Attenuated vaccines are also known as:
2. Question: Live attenuated influenza vaccine (FluMist) may be administered to:
3. Question: The reason that two MMR vaccines at least a month apart are recommended is:
4. Question: MMR vaccine is not recommended for pregnant women because:
5. Question: If the MMRV (measles, mumps, rubella, and varicella) combined vaccine is ordered to be given as the first MMR and varicella dose to a child the CDC recommends:
6. Question: The rotavirus vaccine (RotaTeq, Rotarix):
7. Question: Varicella vaccine is recommended to be given to patients who are:
8. Question: Zoster vaccine (Zostavax) is:
9. Question: True contraindications to diphtheria, tetanus, and acellular pertussis (DTaP or Tdap) vaccine include:
10. Question: Hepatitis B vaccine (HBV) is contraindicated in patients who:
11. Question: Human papillomavirus (HPV) vaccine (Gardasil, Cervarix):
12. Question: Influenza vaccine may be administered annually to:
13. Question: Immune globulin serums (IGs):
14. Question: Hepatitis B immune globulin (HBIG) is administered to provide passive immunity to:
15. Question: Rh_o(D) immune globulin (RhoGAM) is given to:
16. Question: Tuberculin purified protein derivative (PPD):
17. Question: Diane may benefit from cyclosporine (Sandimmune). Cyclosporin may be prescribed to:
18. Question: Azathioprine has significant adverse drug effects, including:

Week 5 Chapter 27 Anemia

1. Question: Pernicious anemia is treated with:
2. Question: Premature infants require iron supplementation with:
3. Question: Breastfed infants should receive iron supplementation of:
4. Question: Valerie presents to clinic with menorrhagia. Her hemoglobin is 10.2 and her ferritin is 15 ng/mL. Initial treatment for her anemia would be:
5. Question: Chee is a 15-month-old male whose screening hemoglobin is 10.4 g/dL. Treatment for his anemia would be:
6. Question: Monitoring for a patient taking iron to treat iron deficiency anemia is:
7. Question: Valerie has been prescribed iron to treat her anemia. Education of patients prescribed iron would include:
8. Question: Allie has just had her pregnancy confirmed and is asking about how to ensure a healthy baby. What is the folic acid requirement during pregnancy?
9. Question: Kyle has Crohn’s disease and has a documented folate deficiency. Drug therapy for folate deficiency anemia is:
10. Question: Patients who are being treated for folate deficiency require monitoring of:
11. Question: The treatment of vitamin B₁₂ deficiency is:
12. Question: The dosage of Vitamin B₁₂ to initially treat pernicious anemia is:
13. Question: Before beginning IM Vitamin B₁₂ therapy, which laboratory values should be obtained?
14. Question: ____ should be monitored when Vitamin B₁₂ therapy is started.
15. Question: Anemia due to chronic renal failure is treated with:

Week 5 Chapter 37: HIV

1. Question: The goals of treatment when prescribing antiretroviral medication to patients with HIV include:
2. Question: A challenge faced with antiretroviral therapy (ART) is:
3. Question: Predictors for successful treatment with antiretroviral therapy (ART) in HIV-positive patients include:
4. Question: The goal of antiretroviral therapy (ART) in HIV-positive patients is:
5. Question: Pregnant women who are HIV positive:
6. Question: Antiretroviral therapy is recommended for HIV-positive patients with:
7. Question: If considering starting a patient on the nucleoside reverse transcriptase inhibitor (NRTI) abacavir, the following testing is recommended prior to prescribing:
8. Question: Suzanne is pregnant and has tested HIV positive. Which antiretroviral drug should be avoided in women who are pregnant?
9. Question: The cost of HIV treatment can be prohibitive for any patient. Patients can receive assistance from the:
10. Question: Resistance to antiretroviral therapy (ART) is measured by:
11. Question: Phenotype assays are used to measure ____ of antiretroviral therapy (ART).
12. Question: Patient factors that contribute to antiretroviral therapy (ART) failure include:
13. Question: Patients who are taking antiretroviral therapy (ART) need to have the following monitored:
14. Question: Successful antiretroviral therapy (ART) in an HIV-positive patient is determined by:

Week 6 Chapter 22 Drugs affecting the reproductive system

1. Question: Men who use transdermal testosterone gel (AndroGel) should be advised to avoid:
2. Question: Education when prescribing androgens to male patients includes:
3. Question: Patients who are prescribed exogenous androgens need to be warned that decreased libido:
4. Question: The U.S. Food and Drug Administration (FDA) warns that androgens may cause:
5. Question: Monitoring for a patient who is using androgens includes:
6. Question: Male patients require ____ before and during androgen therapy.
7. Question: Absolute contraindications to estrogen therapy include:
8. Question: Women with an intact uterus should not be prescribed:
9. Question: Women who have migraine with aura should not be prescribed estrogen due to:
10. Question: A 22-year-old women receives a prescription for oral contraceptives. Education for this patient includes:
11. Question: A 19-year-old female is a nasal Staph aureus carrier and is placed on 5 days of rifampin for treatment. Her only other medication is combined oral contraceptives. What education should she receive regarding her medications?
12. Question: A 56-year-old women is complaining of vaginal dryness and dyspareunia. To treat her symptoms with the lowest adverse effects she should be prescribed:
13. Question: Shana is receiving her first medroxyprogesterone (Depo Provera) injection. Shana will need to be monitored for:
14. Question: When prescribing medroxyprogesterone (Depo Provera) injections, essential education would include the adverse drug effects of:
15. Question: Medroxyprogesterone (Depo Provera) injection has an FDA Black Box warning due to:
16. Question: Shana received her first medroxyprogesterone (Depo Provera) injection 6 weeks ago and calls the clinic with a concern that she has been having a light “period” off and on since receiving her Depo shot. What would be the management of Shana?
17. Question: William is a 62-year-old male who is requesting a prescription for sildenafil (Viagra). He should be screened for ____ before prescribing sildenafil.
18. Question: Men who are prescribed sildenafil (Viagra) need ongoing monitoring for:
19. Question: Men who are prescribed an erectile dysfunction drug such as sildenafil (Viagra) should be warned about the risk for:

Week 6 Chapter 31 Contraception

1. Question: Women who are taking an oral contraceptive containing the progesterone drospirenone may require monitoring of:
2. Question: The mechanism of action of oral combined contraceptives which prevents pregnancy is:
3. Question: To improve actual effectiveness of oral contraceptives women should be educated regarding:
4. Question: A contraindication to the use of combined contraceptives is:
5. Question: Obese women may have increased risk of failure with which contraceptive method?
6. Question: Ashley comes to clinic with a request for oral contraceptives. She has successfully used oral contraceptives before and has recently started dating a new boyfriend so would like to restart contraception. She denies recent intercourse and has a negative urine pregnancy test in the clinic. An appropriate plan of care would be:
7. Question: When discussing with a patient the different start methods used for oral combined contraceptives, the advantage of a Sunday start over the other start methods is:
8. Question: The topical patch combined contraceptive (Ortho Evra) is:
9. Question: Progesterone-only pills are recommended for women who:
10. Question: Women who are prescribed progestin-only contraception need education regarding which common adverse drug effects?
11. Question: An advantage of using the NuvaRing vaginal ring for contraception is:
12. Question: Oral emergency contraception (Plan B) is contraindicated in women who:

Week 6 Chapter 38: Hormone Replacement Therapy and Osteoporosis

1. Question: The goals of therapy when prescribing hormone replacement therapy (HRT) include reducing:
2. Question: The optimal maximum time frame for hormone replacement therapy (HRT) or estrogen replacement therapy (ERT) is:
3. Question: Dosage changes of conjugated equine estrogen (Premarin) are made at ____ intervals.
4. The advantage of vaginal estrogen preparations in the treatment of vulvovaginal atrophy and dryness is:
5. Question: Women with an intact uterus should be treated with both estrogen and progestin due to:
6. Question: Ongoing monitoring for women on estrogen replacement therapy (ERT) includes:
7. Question: Kristine would like to start hormone replacement therapy (HRT) to treat the significant vasomotor symptoms she is experiencing during menopause. Education for a woman considering hormone replacement would include:
8. Question: Angela is a black woman who has heard that women of African descent do not need to worry about osteoporosis. What education would you provide Angela about her risk?
9. Question: Drugs that increase the risk of osteoporosis developing include:
10. Question: Selective estrogen receptor modifiers (SERMs) treat osteoporosis by selectively:
11. Question: Sallie has been diagnosed with osteoporosis and is asking about the “once a month” pill to treat her condition. How do bisphosphonates treat osteoporosis?
12. Question: Inadequate Vitamin D intake can contribute to the development of osteoporosis by:
13. Question: Cassie is a 15-year-old female who presents to clinic for a sports physical. Her diet history indicates she drinks less than one glass of milk per day and avoids dairy products to lose weight. What is the recommended daily calcium intake for Cassie?
14. Question: Susan is a 52-year-old perimenopausal woman who is lactose intolerant. What is her recommended calcium and vitamin D requirement?
15. Question: The drug recommended as primary prevention of osteoporosis in women over age 70 years is:
16. Question: The drug recommended as primary prevention of osteoporosis in men over age 70 years is:
17. Question: Intranasal calcitonin is used in the treatment of osteoporosis. Calcitonin therapy is appropriate for which patient?
18. Question: The ongoing monitoring for patients over age 65 years taking alendronate (Fosamax) or any other bisphosphonate is:

Week 6 Chapter 44: STI and Vaginitis

1. Question: The goals of treatment when prescribing for sexually transmitted infections include:
2. Question: The drug of choice for treatment of primary or secondary syphilis is:
3. Question: The drug of choice for treatment of early latent or tertiary syphilis is:
4. Question: Demione is a 24 year old who is 32 weeks pregnant and has tested positive for syphilis. The best treatment for her would be:
5. Question: Treatment for suspected gonorrhea is:
6. Question: When treating suspected gonorrhea in a non-pregnant patient, the patient should be concurrently treated for Chlamydia with:
7. Question: Ongoing monitoring is essential after treating for gonorrhea. The patient should be rescreened for gonorrhea and Chlamydia in:
8. Question: A test of cure is recommended after treating Chlamydia in which patient population?
9. Question: Treatment for chancroid in a non-pregnant patient would be:
10. Question: Jamie was treated for chancroid. Follow-up testing after treatment of chancroid would be:
11. Question: Helima presents with a complaint of vaginal discharge that when tested meets the criteria for bacterial vaginosis. Treatment of bacterial vaginosis in a non-pregnant symptomatic women would be:
12. Question: Besides prescribing antimicrobial therapy, patients with bacterial vaginosis require education regarding:
13. Question: Sydney presents to clinic with vulvovaginal candidiasis. Appropriate treatment for her would be:
14. Question: If a woman presents with recurrent vulvovaginal candidiasis she may be treated with:
15. Question: Zoe presents with genital warts present on her labia. Patient-applied topical therapy for warts includes:
16. Question: Sophie presents to clinic with a malodorous vaginal discharge and is confirmed to have Trichomonas infection. Treatment for her would include:
17. Question: In addition to antimicrobial therapy, patients treated for Trichomonas infection should be educated regarding:

Week7 Ch. 48 Women as Patients

1. Question: Prescribing for women during their childbearing years requires constant awareness of the possibility of:
2. Question: Intimate partner violence is a serious public health problem. It should be screened for:
3. Question: Because of their longer life expectancy, women are more likely than men to experience a disabling condition. Common conditions in older women that can produce disability include:
4. Question: Gender differences between men and women in pharmacokinetics include:
5. Question: Which of the following drug classes is associated with significant differences in metabolism based on gender?
6. Question: Since 40% of bone accrual occurs during adolescence, building bone during this time is critical. Ways to improve bone accrual in adolescents include:
7. Question: The physiologic anemia of pregnancy can be treated with:
8. Question: Hot flashes are often a concern during menopause. Which of the following may help in reducing them?
9. Question: Factors common in women that can affect adherence to a treatment regimen include all of the following EXCEPT:
10. Question: Dysmenorrhea is one of the most common gynecological complaints in young women.
11. Question: The first line of drug treatment for this disorder is:
12. Question: Premenstrual dysphoric disorder (PMDD) occurs in a fairly small number of patients. Theories of the pathology behind PMDD that are supported in research include:
13. Question: Treatment of PMDD that affects all or most of the symptoms includes:
14. Question: Women are now the fastest growing population with HIV infection and AIDS. HIV infected women:
15. Question: Maternal-to-child transmission of HIV infection during pregnancy may be prevented by:
16. Question: Erroneous information about LGBTQ individuals can lead to failure to give accurate advice to them as patients. Which of the following statements are true about lesbians:

Week 7 Chapter 49 Men as Patients

1. Question: The factor that has the greatest effect on males developing male sexual characteristics is:
2. Question: When assessing a male for hypogonadism prior to prescribing testosterone replacement, serum testosterone levels are drawn:
3. Question: Some research supports that testosterone replacement therapy may be indicated in which of the following diagnoses in men?
4. Question: The goal of testosterone replacement therapy is:
5. Question: While on testosterone replacement, hemoglobin and hematocrit levels should be monitored. Levels suggestive of excessive erythrocytosis or abuse are:
6. Question: Monitoring of an older male patient on testosterone replacement includes:
7. Question: When prescribing phosphodiesterase type 5 (PDE-5) inhibitors such as sildenafil (Viagra) patients should be screened for use of:
8. Question: Men who are prescribed phosphodiesterase type 5 (PDE-5) inhibitors for erectile dysfunction should be educated regarding the adverse effects of the drug which include:
9. Question: Male patients who should not be prescribed phosphodiesterase type 5 (PDE-5) inhibitors include:
10. Question: Monitoring of male patients who are using phosphodiesterase type 5 (PDE-5) inhibitors includes:

Week 7 Chapter 50: Pediatric Patients

1. Question: The Pediatric Research Equity Acts requires:
2. Question: The Best Pharmaceuticals for Children Act:
3. Question: The developmental variation in Phase I enzymes has what impact on pediatric prescribing?
4. Question: Developmental variation in renal function has what impact on prescribing for infants and children?
5. Question: Topical corticosteroids are prescribed cautiously in young children due to:
6. Question: Liza is breastfeeding her 2-month-old son and has an infection that requires an antibiotic. What drug factors influence the effect of the drug on the infant?
7. Question: Drugs that are absolutely contraindicated in lactating women include:
8. Question: Zia is a 4 month old with otitis media. Education of his parents regarding administering oral antibiotics to an infant includes:
9. Question: To increase adherence in pediatric patients a prescription medication should:
10. Question: Janie is a 5-month-old breastfed infant with a fever. Treatment for her fever may include: